Bolt Biotherapeutics Inc.

BOLT | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.59

+$0.03 (+0.84%)

At close: Sep 21, 2026, 4:00 PM ET

$3.59

$0 (0.00%)

After-hours: Sep 21, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.84%

(1D)

Rating

Updated: Aug 27, 2026

32.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $6.9M

1D Range

3.38 3.64

52W Range

3.10 7.20

Valuation (TTM)

PE -0.22

PB 0.55

EV/EBITDA -0.39

Valuation (NTM)

Forward PE N/A

Forward PEG -0.02

Price Target $4

Cash Flow

FCF Yield -457.1%

SBC Adj. FCF Yield -494.0%

SBC Impact -8.1%

Margins

Gross Margin 95.7%

Operating Margin -623.0%

FCF Margin -671.0%

Growth (CAGR)

Revenue 3Y | 5Y -11.5% | -0.2%

Dil EPS 3Y | 5Y -91.8% | -54.6%

FCF 3Y | 5Y 33.2% | 20.7%

Returns

ROA -71.2%

ROE -126.2%

ROIC -82.3%

Financial Health

Net Cash

$17.6M

Current Ratio 2.61

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the b...

Sector Healthcare

Industry Biotechnology

Employees 23

IPO Date Feb 4, 2021

Website www.boltbio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+11.42%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞